Frederic Moll, Director at Intersect ENT, holds 809.61K shares in PROCEPT BioRobotics (Ticker: PRCT), holds 0.00 shares in Shockwave Medical (Ticker: SWAV), holds 260.96K shares in Intersect ENT (Ticker: XENT).
Frederic Moll latest transaction was an Uninformative Buy of ―.
What was Frederic Moll's most profitable transaction?
Frederic Moll’s most profitable transaction was an Informative Buy of XENT stock on August 7, 2014. The return on the trade was 109.70%.
What is Frederic Moll's role in Intersect ENT?
Frederic Moll's role in Intersect ENT is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.